03 May 2014 : Research paper
Effect of high dose vitamin C on Epstein-Barr viral infection
Nina MIkirovaACDE, Ronald HunninghakeADOI: 10.12659/MSM.890423
Med Sci Monit 2014; 20:725-732
Abstract
BACKGROUND: Many natural compounds were tested for the ability to suppress viral replication. The present manuscript details an analysis of high dose vitamin C therapy on patients with EBV infection.
MATERIAL AND METHODS: The data were obtained from the patient history database at the Riordan Clinic. Among people in our database who were treated with intravenous vitamin C (7.5 g to 50 g infusions) between 1997 and 2006, 178 patients showed elevated levels of EBV EA IgG (range 25 to 211 AU) and 40 showed elevated levels of EBV VCA IgM (range 25 to 140 AU). Most of these patients had a diagnosis of chronic fatigue syndrome, with the rest being diagnosed as having mononucleosis, fatigue, or EBV infection.
RESULTS: Our data provide evidence that high dose intravenous vitamin C therapy has a positive effect on disease duration and reduction of viral antibody levels. Plasma levels of ascorbic acid and vitamin D were correlated with levels of antibodies to EBV. We found an inverse correlation between EBV VCA IgM and vitamin C in plasma in patients with mononucleosis and CFS meaning that patients with high levels of vitamin C tended to have lower levels of antigens in the acute state of disease. In addition, a relation was found between vitamin D levels and EBV EA IgG with lower levels of EBV early antigen IgG for higher levels of vitamin D.
CONCLUSIONS: The clinical study of ascorbic acid and EBV infection showed the reduction in EBV EA IgG and EBV VCA IgM antibody levels over time during IVC therapy that is consistent with observations from the literature that millimolar levels of ascorbate hinder viral infection and replication in vitro.
Keywords: Ascorbic Acid - therapeutic use, Antigens, Viral - immunology, Antibodies, Viral - blood, Databases, Factual, Dose-Response Relationship, Drug, Epstein-Barr Virus Infections - virology, Herpesvirus 4, Human - physiology, Lymphocytes - immunology
3291 60
Editorial
01 September 2023 : Editorial
Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2DOI: 10.12659/MSM.942244
Med Sci Monit 2023; 29:e942244
In Press
22 Sep 2023 : Clinical Research
Symptomatology of RSV, COVID-19, and Influenza Infections in Hospitalized ChildrenMed Sci Monit In Press; DOI: 10.12659/MSM.941229
21 Sep 2023 : Clinical Research
The Impact of Implementing the Vortex Approach on Airway Management Performance in Stressed Medical Student...Med Sci Monit In Press; DOI: 10.12659/MSM.940372
20 Sep 2023 : Clinical Research
A Retrospective Study to Compare Pharyngeal Anatomical Changes Measured Before and After Treatment for Malo...Med Sci Monit In Press; DOI: 10.12659/MSM.941749
20 Sep 2023 : Database Analysis
Comparative Finite Element Analysis of Endocrowns and Traditional Restorations for Endodontically Treated M...Med Sci Monit In Press; DOI: 10.12659/MSM.941314
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952